MedTrace Logo

Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke

NCT00473057 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-05-19

No results posted yet for this study

Summary

This is a open label study to assess the safety of autologous bone marrow transplantation in patients with a ischemic stroke in the middle cerebral artery territory within 90 days from symptoms onset.

Conditions

  • Infarction, Middle Cerebral Artery

Interventions

OTHER

Autologous cell transplantation

Intra-arterial or intravenous delivery of autologous bone marrow cells

Sponsors & Collaborators

  • Ministry of Science and Technology, Brazil

    collaborator OTHER

  • Ministry of Health, Brazil

    collaborator OTHER_GOV

  • National Research Council, Brazil

    collaborator OTHER

  • Universidade Federal do Rio de Janeiro

    lead OTHER

Principal Investigators

  • Charles André, MD, PhD · Universidade Federal do Rio de Janeiro

  • Gabriel R de Freitas, MD, PhD · Universidade Federal do Rio de Janeiro

  • Rosalia Mendez-Otero, Md, PhD · Universidade Federal do Rio de Janeiro

  • Lea Mirian Barbosa da Fonseca, MD, PhD · Universidade Federal do Rio de Janeiro

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00473057 on ClinicalTrials.gov